Rituximab treatment for lupus nephritis: A systematic review.
CONCLUSION: The study systematically analyzed the effectiveness and safety of rituximab for lupus nephritis, which suggested that the complete remission rate of rituximab in the treatment of lupus nephritis was a significantly higher than that of cyclophosphamide group, while the effectiveness and safety was of no difference compared with cyclophosphamide and mycophenolate mofetil.
PMID: 32593276 [PubMed - in process]
Source: Clinical and Investigative Medicine - Category: Biomedical Science Authors: Yuan Z, Xie Q, Wu X, Tan B, Zhang X Tags: Clin Invest Med Source Type: research
More News: Biomedical Science | Databases & Libraries | Lupus | Nephritis | Rituxan | Statistics | Study